This content is from: Premium
What’s Behind EcoR1’s Healthy Returns
The one-time II Rising Star posted another strong gain in a year when many other life sciences hedge funds lost money.
EcoR1 Capital has once again posted strong results.The life sciences fund headed by Oleg Nodelman was up 29 percent last year, according to an investor.This is especially impressive given that 2021 was a rough year for many life sciences hedge funds, especially those that load up on fledgling biopharma stocks
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.